ghk-cu third party tested Hair & Scalp Serum 2400mg 4% GHK-Cu - Valor Peptides

Topical GHK-Cu dosage is less standardized

Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6

However, the RECORD trial showed that rosiglitazone treatment is associated with an increased risk for heart failure but not for myocardial infarctions, stroke, or cardiovascular mortality (30, 31)

Cell turnover that might normally take 28-40 days accelerates

This article summarizes topical peptides with proven efficacy in controlled in vivo studies

You can learn more about how we ensure our content is accurate and current by reading our editorial policy